US Patent 7118755 Herpes viruses for immune modulation
Patent 7118755 was granted and assigned to Biovex Limited on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Robert S. Coffin0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+262 characters)
Article
Patent abstract
An attenuated herpes virus which lacks a functional vhs gene or a functional equivalent thereof, but which has a functional UL43 gene or functional equivalent thereof, stimulates an immune response when dendritic cells are infected with the virus.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07118755 Herpes viruses for immune modulation US Patent 7118755 Herpes viruses for immune modulation
Infobox
Patent Number
071187550
Patent Number
71187550
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071187550
Date of Patent
October 10, 2006
0Patent Application Number
107668970
Date Filed
January 30, 2004
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07118755 Herpes viruses for immune modulation
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07118755
Date of patent
October 10, 2006
Patent application number
10766897
Date Filed
January 30, 2004
Patent primary examiner
Find more entities like US Patent 7118755 Herpes viruses for immune modulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
